CMS approves left atrial appendage occlusion registry

The Centers for Medicare & Medicaid Services (CMS) approved the left atrial appendage (LAA) occlusion registry on Aug. 17 to assess patients undergoing percutaneous and epicardial based LAA occlusion procedures to reduce the risk of stroke.

Hospitals participating in the registry submit data each quarter to the American College of Cardiology (ACC) Foundation’s National Cardiovascular Data Registry (NCDR). The NCDR consists of eight hospital-based registries and two outpatient registries aimed at measuring outcomes and increasing the quality of care.

The registry enrolls adults with atrial fibrillation who undergo LAA occlusion. The ACC expects to complete the study in 2026.

The primary outcome measures are the proportion of patients with a major complication and the proportion of patients experiencing any of the following: Procedure aborted, conversion to open heart, hemorrhagic, ischemic or undetermined stroke, any effusion requiring drainage or surgery, device embolization, systemic embolism or major bleeding event.

In February, CMS released the final national coverage determination for percutaneous LAA closure for non-valvular atrial fibrillation.

As of now, the Watchman (Boston Scientific) is the only FDA-approved LAA closure device. The ACC launched the LAA occlusion registry in December 2015, less than a week after the ACC, Society for Cardiovascular Angiography and the Heart Rhythm Society released a consensus statement on LAA occlusion procedures and devices.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."